These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 8883267

  • 1. Conjunctive administration of intravenous heparin attenuates cross-linked fibrin degradation in patients treated with streptokinase.
    Galvani M, Abendschein DR, Ferrini D, Ottani F, Rusticali F, Eisenberg PR.
    Thromb Haemost; 1996 Sep; 76(3):339-43. PubMed ID: 8883267
    [Abstract] [Full Text] [Related]

  • 2. Failure of fixed dose intravenous heparin to suppress increases in thrombin activity after coronary thrombolysis with streptokinase.
    Galvani M, Abendschein DR, Ferrini D, Ottani F, Rusticali F, Eisenberg PR.
    J Am Coll Cardiol; 1994 Nov 15; 24(6):1445-52. PubMed ID: 7930274
    [Abstract] [Full Text] [Related]

  • 3. Reactivation of coagulation after stopping infusions of recombinant hirudin and unfractionated heparin in unstable angina and myocardial infarction without ST elevation: results of a randomized trial. OASIS Pilot Study Investigators. Organization to Assess Strategies for Ischemic++ Syndromes.
    Flather MD, Weitz JI, Yusuf S, Pogue J, Sussex B, Campeau J, Gill J, Schuld R, Joyner CD, Morris AL, Lai C, Théroux P, Marquis JF, Chan YK, Venkatesh G, Jessel A.
    Eur Heart J; 2000 Sep 15; 21(17):1473-81. PubMed ID: 10952840
    [Abstract] [Full Text] [Related]

  • 4. Validity of enzyme-linked immunosorbent assays of cross-linked fibrin degradation products as a measure of clot lysis.
    Eisenberg PR, Jaffe AS, Stump DC, Collen D, Bovill EG.
    Circulation; 1990 Oct 15; 82(4):1159-68. PubMed ID: 2119264
    [Abstract] [Full Text] [Related]

  • 5. Systemic thrombin generation and activity resistant to low molecular weight heparin administered prior to streptokinase in patients with acute myocardial infarction.
    Nilsen DW, Gøransson L, Larsen AI, Hetland O, Kierulf P.
    Thromb Haemost; 1997 Jan 15; 77(1):57-61. PubMed ID: 9031450
    [Abstract] [Full Text] [Related]

  • 6. Sustained fibrinolysis after administration of t-PA despite its short half-life in the circulation.
    Eisenberg PR, Sherman LA, Tiefenbrunn AJ, Ludbrook PA, Sobel BE, Jaffe AS.
    Thromb Haemost; 1987 Feb 03; 57(1):35-40. PubMed ID: 3109058
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Early decrease in coagulation activity after myocardial infarction is associated with lower risk of new ischaemic events: observations from the ESTEEM Trial.
    Christersson C, Oldgren J, Bylock A, Siegbahn A, Wallentin L.
    Eur Heart J; 2007 Mar 03; 28(6):692-8. PubMed ID: 17314111
    [Abstract] [Full Text] [Related]

  • 11. Hemorrhage vs rethrombosis after thrombolysis for acute myocardial infarction.
    Timmis GC, Mammen EF, Ramos RG, Gordon S, Gangadharan V, Hauser AM, Westveer DC, Stewart JR.
    Arch Intern Med; 1986 Apr 03; 146(4):667-72. PubMed ID: 3963947
    [Abstract] [Full Text] [Related]

  • 12. Influence of heparin on fibrinogen and D-dimer plasma levels in acute myocardial infarction treated with streptokinase.
    Salvioni A, Marenzi GC, Agostoni P, Grazi S, Guazzi MD.
    Eur Heart J; 1994 May 03; 15(5):654-9. PubMed ID: 8056006
    [Abstract] [Full Text] [Related]

  • 13. Thrombin generation, inhibition and clinical outcomes in patients with acute myocardial infarction treated with thrombolytic therapy and heparin: results from the GUSTO-I Trial. GUSTO-I Hemostasis Substudy Group. Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries.
    Granger CB, Becker R, Tracy RP, Califf RM, Topol EJ, Pieper KS, Ross AM, Roth S, Lambrew C, Bovill EG.
    J Am Coll Cardiol; 1998 Mar 01; 31(3):497-505. PubMed ID: 9502626
    [Abstract] [Full Text] [Related]

  • 14. Accelerated infusion of streptokinase in acute myocardial infarction results in better TIMI flow grade in infarct-related artery.
    Dwivedi SK, Saran RK, Narain VS, Bansal S, Gupta R, Puri VK.
    Indian Heart J; 2000 Mar 01; 52(1):40-4. PubMed ID: 10820932
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [The absence of a procoagulant effect after TNK-t-PA: a comparison with streptokinase and rt-PA].
    De Marco E, Andreotti F, van de Greef W, Quaranta G, Biasucci LM, Kol A, Maseri A, Rebuzzi AG.
    Cardiologia; 1998 Nov 01; 43(11):1209-13. PubMed ID: 9922587
    [Abstract] [Full Text] [Related]

  • 17. [The significance of changes in fibrinogen levels during thrombolytic therapy in myocardial infarct].
    Malý J, Pecka M, Pidrman V, Hamet A, Gregor J, Vodicka L, Siroký O, Tichý M.
    Vnitr Lek; 1991 Mar 01; 37(3):229-37. PubMed ID: 2031311
    [Abstract] [Full Text] [Related]

  • 18. [Intravenous thrombolysis in myocardial infarction. Influence of the quality of the anticoagulation on the early recurrence rate of angina or infarction].
    Camilleri JF, Bonnet JL, Bouvier JL, Levy G, Djiane P, Bory M, Serradimigni A.
    Arch Mal Coeur Vaiss; 1988 Sep 01; 81(9):1037-41. PubMed ID: 3143325
    [Abstract] [Full Text] [Related]

  • 19. Activation of protein C and hemodynamic recovery after coronary artery bypass surgery.
    Raivio P, Fernández JA, Kuitunen A, Griffin JH, Lassila R, Petäjä J.
    J Thorac Cardiovasc Surg; 2007 Jan 01; 133(1):44-51. PubMed ID: 17198779
    [Abstract] [Full Text] [Related]

  • 20. Late activation of the fibrinolytic system in myocardial infarction treated with thrombolytic therapy. Influence of the coronary anatomical substrate.
    Salvioni A, Perego GB, Marenzi G, Lauri G, Giraldi F, Grazi S, Guazzi MD.
    Eur Heart J; 1996 Feb 01; 17(2):230-6. PubMed ID: 8732376
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.